The effect of clopidogrel on apoptosis--an in vivo study

Ridvan Yalcin1, Aycan Erkan, Mehmet Ali Ergun

  • 1Department of Cardiology, Faculty of Medicine, Gazi University, Besevler, Ankara 06510, Turkey. ergun@tr.net

Insights

Clopidogrel may influence cardiovascular disease by affecting lymphocyte apoptosis. This study investigated clopidogrel

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Cell Biology

Background:

  • Clopidogrel is a key drug in cardiovascular medicine, particularly for patients with coronary stents.
  • In-stent restenosis, a complication after stenting, is linked to neointimal hyperplasia.
  • Lymphocytes, especially T-cells, are implicated in atherosclerosis and plaque formation.

Purpose of the Study:

  • To examine the impact of clopidogrel on human lymphocyte apoptosis.
  • To explore a potential mechanism linking clopidogrel, neointimal hyperplasia, and cardiovascular disease progression.

Main Methods:

  • Utilized a DNA fragmentation assay to measure apoptosis.
  • Investigated the effects of clopidogrel on isolated human lymphocytes.

Main Results:

  • The study assessed clopidogrel's influence on lymphocyte cell death pathways.
  • Results provide insights into how clopidogrel might modulate immune cell responses relevant to cardiovascular conditions.

Conclusions:

  • Clopidogrel's role in cardiovascular pathogenesis may involve modulating lymphocyte apoptosis.
  • Understanding this interaction could inform strategies for managing cardiovascular diseases and preventing complications like in-stent restenosis.